Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension Combined Diastolic and Systolic”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableNot Yet RecruitingNCT07089290
What this trial is testing

A Study Protocol to Assess the Effectiveness of Nurse-Led Telehealth Intervention for Hypertension Control in Nepal

Who this might be right for
Hypertension Combined Diastolic and Systolic
Kathmandu University School of Medical Sciences 706
Large-scale testing (Phase 3)Study completedNCT05170061
What this trial is testing

24 Hour Ambulatory Cardiac Oxygen Consumption

Who this might be right for
Hypertension
State University of New York at Buffalo 26
Large-scale testing (Phase 3)Study completedNCT00350168
What this trial is testing

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Who this might be right for
Hypertension
Novartis 647
Large-scale testing (Phase 3)Study completedNCT00387517
What this trial is testing

Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension

Who this might be right for
Hypertension
Novartis 726
Post-approval studies (Phase 4)Study completedNCT00942994
What this trial is testing

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Who this might be right for
Hypertension
Novartis 412
Large-scale testing (Phase 3)Study completedNCT00386139
What this trial is testing

A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients

Who this might be right for
Hypertension
Novartis 881
Post-approval studies (Phase 4)Study completedNCT00853957
What this trial is testing

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Who this might be right for
Hypertension
Novartis 443
Post-approval studies (Phase 4)Study completedNCT00926289
What this trial is testing

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 894
Large-scale testing (Phase 3)Study completedNCT00289887
What this trial is testing

Obese Hypertension Study (0954-315)

Who this might be right for
Hypertension
Organon and Co 261
Large-scale testing (Phase 3)Study completedNCT01977794
What this trial is testing

Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension

Who this might be right for
Hypertension
Merck KGaA, Darmstadt, Germany 200
Not applicableLooking for participantsNCT07383220
What this trial is testing

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

Who this might be right for
Resistant HypertensionHemodynamic InstabilityEssential (Primary) Hypertension+5 more
Mohamed Mohamed Ali Morgan 50
Post-approval studies (Phase 4)Study completedNCT00927394
What this trial is testing

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

Who this might be right for
Hypertension
Novartis 1,143
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc
Post-approval studies (Phase 4)Study completedNCT00698646
What this trial is testing

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Who this might be right for
Hypertension
Novartis Pharmaceuticals 384